Kindred Biosciences
KIN
#7455
Rank
โ‚ฌ0.36 B
Marketcap
7,94ย โ‚ฌ
Share price
0.11%
Change (1 day)
N/A
Change (1 year)

Revenue for Kindred Biosciences (KIN)

Revenue in 2021 (TTM): โ‚ฌ6.68 Million

According to Kindred Biosciences 's latest financial reports the company's current revenue is โ‚ฌ6.8 Million. In 2020 the company made a revenue of โ‚ฌ36.23 Million an increase over the revenue in the year 2019 that were of โ‚ฌ3.67 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kindred Biosciences from 2019 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ6.68 M-81.54%
2020โ‚ฌ36.23 M885.15%
2019โ‚ฌ3.67 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Zoetis
ZTS
โ‚ฌ8.07 B 118,459.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.17 B 810,334.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.03 B 749,582.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Phibro Animal Health
PAHC
โ‚ฌ1.20 B 17,559.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Petco
WOOF
โ‚ฌ5.19 B 76,174.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
โ‚ฌ0.21 B 3,115.85%๐Ÿ‡บ๐Ÿ‡ธ USA